Frontiers in Oncology (Nov 2022)
Imaging hypoxia in endometrial cancer: How and why should it be done?
- Nandita M. deSouza,
- Nandita M. deSouza,
- Ananya Choudhury,
- Ananya Choudhury,
- Mel Greaves,
- James P. B. O’Connor,
- James P. B. O’Connor,
- James P. B. O’Connor,
- Peter J. Hoskin,
- Peter J. Hoskin
Affiliations
- Nandita M. deSouza
- Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom
- Nandita M. deSouza
- Department of Imaging, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom
- Ananya Choudhury
- Radiation Oncology, The Christie National Health Service (NHS) Foundation Trust Manchester, Manchester, United Kingdom
- Ananya Choudhury
- The Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
- Mel Greaves
- Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom
- James P. B. O’Connor
- Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom
- James P. B. O’Connor
- Department of Imaging, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom
- James P. B. O’Connor
- The Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
- Peter J. Hoskin
- The Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
- Peter J. Hoskin
- Radiation Oncology, Mount Vernon Cancer Centre, Northwood, United Kingdom
- DOI
- https://doi.org/10.3389/fonc.2022.1020907
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords